Altium Capital Management LLC
CIK 1746382 · Holdings on Mar 31, 2025 · First reported May 13, 2025
Top ten holdings
Q1 2025- ZVRA28.00%
- EOLS10.35%
- XTNT9.90%
- AVDL9.53%
- CTNM6.16%
- PROF6.09%
- XENE5.87%
- EPI4.82%
- 83086J2004.18%
- ACOG2.61%
Share classes counted separately87.51%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- ZVRAWeight increased · +23.19 pp4.81% → 28.00%Shares -562.67K (-30.41%)
- XTNTWeight increased · +8.88 pp1.02% → 9.90%Shares -162.41K (-2.19%)
- AVDLWeight increased · +8.05 pp1.48% → 9.53%Shares -33.34K (-7.37%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 22
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | ZVRAZEVRA THERAPEUTICS INCCOM NEW View history and evidence | $9.64M | 28.00% | 1.29M shares | 4.81% → 28.00%+23.19 pp -562.67K (-30.41%) | Reduced | ↗▾ |
| 02 | EOLSEVOLUS INC View history and evidence | $3.56M | 10.35% | 296.19K shares | 2.36% → 10.35%+7.99 pp -388.81K (-56.76%) | Reduced | ↗▾ |
| 03 | XTNTXTANT MEDICAL HOLDINGS INCCOM NEW View history and evidence | $3.41M | 9.90% | 7.25M shares | 1.02% → 9.90%+8.88 pp -162.41K (-2.19%) | Reduced | ↗▾ |
| 04 | AVDLAVADEL PHARMACEUTICALSCOM SHS View history and evidence | $3.28M | 9.53% | 419.13K shares | 1.48% → 9.53%+8.05 pp -33.34K (-7.37%) | Reduced | ↗▾ |
| 05 | CTNMCONTINEUM THERAPEUTICS INC-ACL A View history and evidence | $2.12M | 6.16% | 303.86K shares | 1.52% → 6.16%+4.64 pp -30.14K (-9.02%) | Reduced | ↗▾ |
| 06 | PROFPROFOUND MEDICAL CORPCOM NEW View history and evidence | $2.10M | 6.09% | 360.59K shares | 1.13% → 6.09%+4.96 pp -124.41K (-25.65%) | Reduced | ↗▾ |
| 07 | XENEXENON PHARMACEUTICALS INC View history and evidence | $2.02M | 5.87% | 60.25K shares | 3.52% → 5.87%+2.35 pp -227.75K (-79.08%) | Reduced | ↗▾ |
| 08 | EPIESSA PHARMA INCCOM NEW View history and evidence | $1.66M | 4.82% | 1.05M shares | 0.80% → 4.82%+4.02 pp -377.63K (-26.44%) | Reduced | ↗▾ |
| 09 | 83086J200SKYE BIOSCIENCE INCCOM NEW View history and evidence | $1.44M | 4.18% | 904.87K shares | 1.00% → 4.18%+3.18 pp -234.13K (-20.56%) | Reduced | ↗▾ |
| 10 | ACOGALPHA COGNITION INCCOM NEW View history and evidence | $897.73K | 2.61% | 177.42K shares | 0.50% → 2.61%+2.11 pp -97.58K (-35.49%) | Reduced | ↗▾ |
Options overlay 2
$7.07M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
ALNYALNYLAM PHARMACEUTICALS INC View history and evidence | Put | 25.00K | $6.75M | +25.00K | ▾ |
XENEXENON PHARMACEUTICALS INC View history and evidence | Call | 9.40K | $315.37K | 0 (0.00%) | ▾ |
2 / 2 options · preview only
Exited positions 48
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| ADMA ADMA BIOLOGICS INC | Non-derivative | -1,395,000 | -$23.92M | SEC filing ↗ | SEC filing ↗ |
| VERA VERA THERAPEUTICS INC | Non-derivative | -432,000 | -$18.27M | SEC filing ↗ | SEC filing ↗ |
| SRPT SAREPTA THERAPEUTICS INC | Non-derivative | -127,000 | -$15.44M | SEC filing ↗ | SEC filing ↗ |
3 / 48 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1746382 · Period 2025-03-31
Data loaded 2026-09-23 · First reported 2025-05-13
Amendments and versions
{
"amendments_merged": [
{
"action": "REPLACE",
"accession": "0001420506-25-000988",
"cover_total": 41500012,
"filing_date": "2025-05-13",
"claimed_type": "RESTATEMENT",
"confidential": false,
"positions_added": 0,
"positions_restated": 2,
"positions_cancelled": 0
}
],
"prior_versions": [
{
"accession": "0001420506-25-000948",
"filing_date": "2025-05-09",
"confidential": false,
"cover_table_value_total_raw": 43789879
}
],
"cover_table_value": 41500012
}Take these holdings further.
This page includes 24 of 24 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 24 of 24 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1746382","quarter":"2025Q1","page_size":100}
get_institutional_manager_history
{"cik":"1746382","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.